FDA approves Moderna’s new lower-dose COVID-19 vaccine by John Gerstner | Posted on Moderna’s new option is a lower-dose version that is a step toward next-generation coronavirus vaccines.
Postmaster general warns USPS could run out of money by next year if ‘status quo’ continues March 18, 2026
